Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorWarren, Anne Y.
dc.contributor.authorHarrison, David
dc.date.accessioned2018-09-06T15:30:06Z
dc.date.available2018-09-06T15:30:06Z
dc.date.issued2018-12
dc.identifier.citationWarren , A Y & Harrison , D 2018 , ' WHO/ISUP classification, grading and pathological staging of renal cell carcinoma : standards and controversies ' , World Journal of Urology , vol. 36 , no. 12 , pp. 1913-1926 . https://doi.org/10.1007/s00345-018-2447-8en
dc.identifier.issn0724-4983
dc.identifier.otherPURE: 255749918
dc.identifier.otherPURE UUID: 337ffa15-dc7d-41ca-b50c-c70a1f63bec2
dc.identifier.otherScopus: 85052147888
dc.identifier.otherWOS: 000452271200004
dc.identifier.urihttp://hdl.handle.net/10023/15983
dc.description.abstractPurpose: Pathological parameters assessed on biopsies and resection specimens have a pivotal role in the diagnosis, prognosis and management of patients with renal cell carcinoma (RCC). Methods: A non-systematic literature search was performed, updated to January 2018, to identify key standards and controversies in the pathological classification, grading and staging of RCC. Results: Although most RCCs exhibit characteristic morphology that enables easy categorisation, RCCs show considerable morphological heterogeneity and it is not uncommon for there to be difficulty in assigning a tumour type, especially with rarer tumour subtypes. The differentiation between benign and malignant oncocytic tumours remains a particular challenge. The development of additional immunohistochemical and molecular tests is needed to facilitate tumour typing, because of the prognostic and therapeutic implications, and to enable more reliable identification of poorly differentiated metastatic tumours as being of renal origin. Any new tests need to be applicable to small biopsy samples, to overcome the heterogeneity of renal tumours. There is also a need to facilitate identification of tumour types that have genetic implications, to allow referral and management at specialist centres. Digital pathology has a potential role in such referral practice. Conclusion: Much has been done to standardise pathological assessment of renal cell carcinomas in recent years, but there still remain areas of difficulty in classification and grading of these heterogeneous tumours.
dc.format.extent14
dc.language.isoeng
dc.relation.ispartofWorld Journal of Urologyen
dc.rights© The Author(s) 2018. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en
dc.subjectGradingen
dc.subjectPathologyen
dc.subjectRenal cell carcinomaen
dc.subjectReviewen
dc.subjectStagingen
dc.subjectRB Pathologyen
dc.subjectRZ Other systems of medicineen
dc.subjectUrologyen
dc.subject.lccRBen
dc.subject.lccRZen
dc.titleWHO/ISUP classification, grading and pathological staging of renal cell carcinoma : standards and controversiesen
dc.typeJournal itemen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.identifier.doihttps://doi.org/10.1007/s00345-018-2447-8
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record